共 50 条
- [1] Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer Benefit or Caution? AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (05): : 190 - 195
- [6] The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (04): : 368 - 373
- [7] Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting La radiologia medica, 2022, 127 : 206 - 213
- [8] Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase 1 Trial for Patients With Low- and Intermediate-Risk Prostate Cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (02): : 334 - 342
- [10] Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting RADIOLOGIA MEDICA, 2022, 127 (02): : 206 - 213